ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Heparin (Low Molecular Weight) Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-27N7109
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Heparin Low Molecular Weight Market Insights and Forecast to 2028
BUY CHAPTERS

Global Heparin (Low Molecular Weight) Market Research Report 2024

Code: QYRE-Auto-27N7109
Report
January 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aspen
Sanofi Aventis
Pfizer Inc
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Heparin (Low Molecular Weight) Market Size

The global Heparin (Low Molecular Weight) market was valued at US$ 338.6 million in 2023 and is anticipated to reach US$ 432.2 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.

Heparin (Low Molecular Weight) Market

Heparin (Low Molecular Weight) Market

North American market for Heparin (Low Molecular Weight) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Heparin (Low Molecular Weight) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Heparin (Low Molecular Weight) include Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow and Yantai Dongcheng Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Heparin (Low Molecular Weight), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin (Low Molecular Weight).

Report Scope

The Heparin (Low Molecular Weight) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heparin (Low Molecular Weight) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin (Low Molecular Weight) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Heparin (Low Molecular Weight) Market Report

Report Metric Details
Report Name Heparin (Low Molecular Weight) Market
Accounted market size in 2023 US$ 338.6 million
Forecasted market size in 2030 US$ 432.2 million
CAGR 3.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Enoxaparin
  • Dalteparin
  • Tinzaparin
  • Fraxiparine
Segment by Application
  • Treatment of Venous Thromboembolism
  • Complications of Pregnancy
  • Cardioversion of Atrial Fibrillation/Flutter
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Heparin (Low Molecular Weight) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Heparin (Low Molecular Weight) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Heparin (Low Molecular Weight) Market growing?

Ans: The Heparin (Low Molecular Weight) Market witnessing a CAGR of 3.6% during the forecast period 2024-2030.

What is the Heparin (Low Molecular Weight) Market size in 2030?

Ans: The Heparin (Low Molecular Weight) Market size in 2030 will be US$ 432.2 million.

Who are the main players in the Heparin (Low Molecular Weight) Market report?

Ans: The main players in the Heparin (Low Molecular Weight) Market are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group

What are the Application segmentation covered in the Heparin (Low Molecular Weight) Market report?

Ans: The Applications covered in the Heparin (Low Molecular Weight) Market report are Treatment of Venous Thromboembolism, Complications of Pregnancy, Cardioversion of Atrial Fibrillation/Flutter, Others

What are the Type segmentation covered in the Heparin (Low Molecular Weight) Market report?

Ans: The Types covered in the Heparin (Low Molecular Weight) Market report are Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine

1 Heparin (Low Molecular Weight) Market Overview
1.1 Product Overview and Scope of Heparin (Low Molecular Weight)
1.2 Heparin (Low Molecular Weight) Segment by Type
1.2.1 Global Heparin (Low Molecular Weight) Market Value Comparison by Type (2024-2030)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Heparin (Low Molecular Weight) Segment by Application
1.3.1 Global Heparin (Low Molecular Weight) Market Value by Application: (2024-2030)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Global Heparin (Low Molecular Weight) Market Size Estimates and Forecasts
1.4.1 Global Heparin (Low Molecular Weight) Revenue 2019-2030
1.4.2 Global Heparin (Low Molecular Weight) Sales 2019-2030
1.4.3 Global Heparin (Low Molecular Weight) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Heparin (Low Molecular Weight) Market Competition by Manufacturers
2.1 Global Heparin (Low Molecular Weight) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Heparin (Low Molecular Weight) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Heparin (Low Molecular Weight) Average Price by Manufacturers (2019-2024)
2.4 Global Heparin (Low Molecular Weight) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heparin (Low Molecular Weight), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heparin (Low Molecular Weight), Product Type & Application
2.7 Heparin (Low Molecular Weight) Market Competitive Situation and Trends
2.7.1 Heparin (Low Molecular Weight) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Heparin (Low Molecular Weight) Players Market Share by Revenue
2.7.3 Global Heparin (Low Molecular Weight) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heparin (Low Molecular Weight) Retrospective Market Scenario by Region
3.1 Global Heparin (Low Molecular Weight) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Heparin (Low Molecular Weight) Global Heparin (Low Molecular Weight) Sales by Region: 2019-2030
3.2.1 Global Heparin (Low Molecular Weight) Sales by Region: 2019-2024
3.2.2 Global Heparin (Low Molecular Weight) Sales by Region: 2025-2030
3.3 Global Heparin (Low Molecular Weight) Global Heparin (Low Molecular Weight) Revenue by Region: 2019-2030
3.3.1 Global Heparin (Low Molecular Weight) Revenue by Region: 2019-2024
3.3.2 Global Heparin (Low Molecular Weight) Revenue by Region: 2025-2030
3.4 North America Heparin (Low Molecular Weight) Market Facts & Figures by Country
3.4.1 North America Heparin (Low Molecular Weight) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Heparin (Low Molecular Weight) Sales by Country (2019-2030)
3.4.3 North America Heparin (Low Molecular Weight) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heparin (Low Molecular Weight) Market Facts & Figures by Country
3.5.1 Europe Heparin (Low Molecular Weight) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Heparin (Low Molecular Weight) Sales by Country (2019-2030)
3.5.3 Europe Heparin (Low Molecular Weight) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin (Low Molecular Weight) Market Facts & Figures by Country
3.6.1 Asia Pacific Heparin (Low Molecular Weight) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Heparin (Low Molecular Weight) Sales by Country (2019-2030)
3.6.3 Asia Pacific Heparin (Low Molecular Weight) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin (Low Molecular Weight) Market Facts & Figures by Country
3.7.1 Latin America Heparin (Low Molecular Weight) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Heparin (Low Molecular Weight) Sales by Country (2019-2030)
3.7.3 Latin America Heparin (Low Molecular Weight) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin (Low Molecular Weight) Market Facts & Figures by Country
3.8.1 Middle East and Africa Heparin (Low Molecular Weight) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Heparin (Low Molecular Weight) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Heparin (Low Molecular Weight) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Heparin (Low Molecular Weight) Sales by Type (2019-2030)
4.1.1 Global Heparin (Low Molecular Weight) Sales by Type (2019-2024)
4.1.2 Global Heparin (Low Molecular Weight) Sales by Type (2025-2030)
4.1.3 Global Heparin (Low Molecular Weight) Sales Market Share by Type (2019-2030)
4.2 Global Heparin (Low Molecular Weight) Revenue by Type (2019-2030)
4.2.1 Global Heparin (Low Molecular Weight) Revenue by Type (2019-2024)
4.2.2 Global Heparin (Low Molecular Weight) Revenue by Type (2025-2030)
4.2.3 Global Heparin (Low Molecular Weight) Revenue Market Share by Type (2019-2030)
4.3 Global Heparin (Low Molecular Weight) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Heparin (Low Molecular Weight) Sales by Application (2019-2030)
5.1.1 Global Heparin (Low Molecular Weight) Sales by Application (2019-2024)
5.1.2 Global Heparin (Low Molecular Weight) Sales by Application (2025-2030)
5.1.3 Global Heparin (Low Molecular Weight) Sales Market Share by Application (2019-2030)
5.2 Global Heparin (Low Molecular Weight) Revenue by Application (2019-2030)
5.2.1 Global Heparin (Low Molecular Weight) Revenue by Application (2019-2024)
5.2.2 Global Heparin (Low Molecular Weight) Revenue by Application (2025-2030)
5.2.3 Global Heparin (Low Molecular Weight) Revenue Market Share by Application (2019-2030)
5.3 Global Heparin (Low Molecular Weight) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Aspen
6.1.1 Aspen Corporation Information
6.1.2 Aspen Description and Business Overview
6.1.3 Aspen Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Aspen Heparin (Low Molecular Weight) Product Portfolio
6.1.5 Aspen Recent Developments/Updates
6.2 Sanofi-aventis
6.2.1 Sanofi-aventis Corporation Information
6.2.2 Sanofi-aventis Description and Business Overview
6.2.3 Sanofi-aventis Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-aventis Heparin (Low Molecular Weight) Product Portfolio
6.2.5 Sanofi-aventis Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Heparin (Low Molecular Weight) Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Opocrin
6.4.1 Opocrin Corporation Information
6.4.2 Opocrin Description and Business Overview
6.4.3 Opocrin Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Opocrin Heparin (Low Molecular Weight) Product Portfolio
6.4.5 Opocrin Recent Developments/Updates
6.5 CSBIO
6.5.1 CSBIO Corporation Information
6.5.2 CSBIO Description and Business Overview
6.5.3 CSBIO Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CSBIO Heparin (Low Molecular Weight) Product Portfolio
6.5.5 CSBIO Recent Developments/Updates
6.6 Dongying Tiandong Pharmaceutical
6.6.1 Dongying Tiandong Pharmaceutical Corporation Information
6.6.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.6.3 Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Product Portfolio
6.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.7 Changzhou Qianhong Bio-pharma
6.6.1 Changzhou Qianhong Bio-pharma Corporation Information
6.6.2 Changzhou Qianhong Bio-pharma Description and Business Overview
6.6.3 Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Product Portfolio
6.7.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
6.8 Techdow
6.8.1 Techdow Corporation Information
6.8.2 Techdow Description and Business Overview
6.8.3 Techdow Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Techdow Heparin (Low Molecular Weight) Product Portfolio
6.8.5 Techdow Recent Developments/Updates
6.9 Yantai Dongcheng Pharmaceutical Group
6.9.1 Yantai Dongcheng Pharmaceutical Group Corporation Information
6.9.2 Yantai Dongcheng Pharmaceutical Group Description and Business Overview
6.9.3 Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Product Portfolio
6.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin (Low Molecular Weight) Industry Chain Analysis
7.2 Heparin (Low Molecular Weight) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin (Low Molecular Weight) Production Mode & Process
7.4 Heparin (Low Molecular Weight) Sales and Marketing
7.4.1 Heparin (Low Molecular Weight) Sales Channels
7.4.2 Heparin (Low Molecular Weight) Distributors
7.5 Heparin (Low Molecular Weight) Customers
8 Heparin (Low Molecular Weight) Market Dynamics
8.1 Heparin (Low Molecular Weight) Industry Trends
8.2 Heparin (Low Molecular Weight) Market Drivers
8.3 Heparin (Low Molecular Weight) Market Challenges
8.4 Heparin (Low Molecular Weight) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Aspen
Sanofi Aventis
Pfizer Inc
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group
List of Tables
    Table 1. Global Heparin (Low Molecular Weight) Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Heparin (Low Molecular Weight) Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Heparin (Low Molecular Weight) Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Heparin (Low Molecular Weight) Sales (Kiloton) of Key Manufacturers (2019-2024)
    Table 5. Global Heparin (Low Molecular Weight) Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Heparin (Low Molecular Weight) Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Heparin (Low Molecular Weight) Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Heparin (Low Molecular Weight) Average Price (US$/Ton) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Heparin (Low Molecular Weight), Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Heparin (Low Molecular Weight), Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Heparin (Low Molecular Weight), Product Type & Application
    Table 12. Global Key Manufacturers of Heparin (Low Molecular Weight), Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Heparin (Low Molecular Weight) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin (Low Molecular Weight) as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Heparin (Low Molecular Weight) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Heparin (Low Molecular Weight) Sales by Region (2019-2024) & (Kiloton)
    Table 18. Global Heparin (Low Molecular Weight) Sales Market Share by Region (2019-2024)
    Table 19. Global Heparin (Low Molecular Weight) Sales by Region (2025-2030) & (Kiloton)
    Table 20. Global Heparin (Low Molecular Weight) Sales Market Share by Region (2025-2030)
    Table 21. Global Heparin (Low Molecular Weight) Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Heparin (Low Molecular Weight) Revenue Market Share by Region (2019-2024)
    Table 23. Global Heparin (Low Molecular Weight) Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Heparin (Low Molecular Weight) Revenue Market Share by Region (2025-2030)
    Table 25. North America Heparin (Low Molecular Weight) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Heparin (Low Molecular Weight) Sales by Country (2019-2024) & (Kiloton)
    Table 27. North America Heparin (Low Molecular Weight) Sales by Country (2025-2030) & (Kiloton)
    Table 28. North America Heparin (Low Molecular Weight) Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Heparin (Low Molecular Weight) Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Heparin (Low Molecular Weight) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Heparin (Low Molecular Weight) Sales by Country (2019-2024) & (Kiloton)
    Table 32. Europe Heparin (Low Molecular Weight) Sales by Country (2025-2030) & (Kiloton)
    Table 33. Europe Heparin (Low Molecular Weight) Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Heparin (Low Molecular Weight) Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Heparin (Low Molecular Weight) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Heparin (Low Molecular Weight) Sales by Region (2019-2024) & (Kiloton)
    Table 37. Asia Pacific Heparin (Low Molecular Weight) Sales by Region (2025-2030) & (Kiloton)
    Table 38. Asia Pacific Heparin (Low Molecular Weight) Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Heparin (Low Molecular Weight) Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Heparin (Low Molecular Weight) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Heparin (Low Molecular Weight) Sales by Country (2019-2024) & (Kiloton)
    Table 42. Latin America Heparin (Low Molecular Weight) Sales by Country (2025-2030) & (Kiloton)
    Table 43. Latin America Heparin (Low Molecular Weight) Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Heparin (Low Molecular Weight) Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Heparin (Low Molecular Weight) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Heparin (Low Molecular Weight) Sales by Country (2019-2024) & (Kiloton)
    Table 47. Middle East & Africa Heparin (Low Molecular Weight) Sales by Country (2025-2030) & (Kiloton)
    Table 48. Middle East & Africa Heparin (Low Molecular Weight) Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Heparin (Low Molecular Weight) Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Heparin (Low Molecular Weight) Sales (Kiloton) by Type (2019-2024)
    Table 51. Global Heparin (Low Molecular Weight) Sales (Kiloton) by Type (2025-2030)
    Table 52. Global Heparin (Low Molecular Weight) Sales Market Share by Type (2019-2024)
    Table 53. Global Heparin (Low Molecular Weight) Sales Market Share by Type (2025-2030)
    Table 54. Global Heparin (Low Molecular Weight) Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Heparin (Low Molecular Weight) Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Heparin (Low Molecular Weight) Revenue Market Share by Type (2019-2024)
    Table 57. Global Heparin (Low Molecular Weight) Revenue Market Share by Type (2025-2030)
    Table 58. Global Heparin (Low Molecular Weight) Price (US$/Ton) by Type (2019-2024)
    Table 59. Global Heparin (Low Molecular Weight) Price (US$/Ton) by Type (2025-2030)
    Table 60. Global Heparin (Low Molecular Weight) Sales (Kiloton) by Application (2019-2024)
    Table 61. Global Heparin (Low Molecular Weight) Sales (Kiloton) by Application (2025-2030)
    Table 62. Global Heparin (Low Molecular Weight) Sales Market Share by Application (2019-2024)
    Table 63. Global Heparin (Low Molecular Weight) Sales Market Share by Application (2025-2030)
    Table 64. Global Heparin (Low Molecular Weight) Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Heparin (Low Molecular Weight) Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Heparin (Low Molecular Weight) Revenue Market Share by Application (2019-2024)
    Table 67. Global Heparin (Low Molecular Weight) Revenue Market Share by Application (2025-2030)
    Table 68. Global Heparin (Low Molecular Weight) Price (US$/Ton) by Application (2019-2024)
    Table 69. Global Heparin (Low Molecular Weight) Price (US$/Ton) by Application (2025-2030)
    Table 70. Aspen Corporation Information
    Table 71. Aspen Description and Business Overview
    Table 72. Aspen Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 73. Aspen Heparin (Low Molecular Weight) Product
    Table 74. Aspen Recent Developments/Updates
    Table 75. Sanofi-aventis Corporation Information
    Table 76. Sanofi-aventis Description and Business Overview
    Table 77. Sanofi-aventis Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 78. Sanofi-aventis Heparin (Low Molecular Weight) Product
    Table 79. Sanofi-aventis Recent Developments/Updates
    Table 80. Pfizer Corporation Information
    Table 81. Pfizer Description and Business Overview
    Table 82. Pfizer Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 83. Pfizer Heparin (Low Molecular Weight) Product
    Table 84. Pfizer Recent Developments/Updates
    Table 85. Opocrin Corporation Information
    Table 86. Opocrin Description and Business Overview
    Table 87. Opocrin Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 88. Opocrin Heparin (Low Molecular Weight) Product
    Table 89. Opocrin Recent Developments/Updates
    Table 90. CSBIO Corporation Information
    Table 91. CSBIO Description and Business Overview
    Table 92. CSBIO Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 93. CSBIO Heparin (Low Molecular Weight) Product
    Table 94. CSBIO Recent Developments/Updates
    Table 95. Dongying Tiandong Pharmaceutical Corporation Information
    Table 96. Dongying Tiandong Pharmaceutical Description and Business Overview
    Table 97. Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 98. Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Product
    Table 99. Dongying Tiandong Pharmaceutical Recent Developments/Updates
    Table 100. Changzhou Qianhong Bio-pharma Corporation Information
    Table 101. Changzhou Qianhong Bio-pharma Description and Business Overview
    Table 102. Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 103. Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Product
    Table 104. Changzhou Qianhong Bio-pharma Recent Developments/Updates
    Table 105. Techdow Corporation Information
    Table 106. Techdow Description and Business Overview
    Table 107. Techdow Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 108. Techdow Heparin (Low Molecular Weight) Product
    Table 109. Techdow Recent Developments/Updates
    Table 110. Yantai Dongcheng Pharmaceutical Group Corporation Information
    Table 111. Yantai Dongcheng Pharmaceutical Group Description and Business Overview
    Table 112. Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 113. Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Product
    Table 114. Yantai Dongcheng Pharmaceutical Group Recent Developments/Updates
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Heparin (Low Molecular Weight) Distributors List
    Table 118. Heparin (Low Molecular Weight) Customers List
    Table 119. Heparin (Low Molecular Weight) Market Trends
    Table 120. Heparin (Low Molecular Weight) Market Drivers
    Table 121. Heparin (Low Molecular Weight) Market Challenges
    Table 122. Heparin (Low Molecular Weight) Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Heparin (Low Molecular Weight)
    Figure 2. Global Heparin (Low Molecular Weight) Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Heparin (Low Molecular Weight) Market Share by Type in 2023 & 2030
    Figure 4. Enoxaparin Product Picture
    Figure 5. Dalteparin Product Picture
    Figure 6. Tinzaparin Product Picture
    Figure 7. Fraxiparine Product Picture
    Figure 8. Global Heparin (Low Molecular Weight) Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Heparin (Low Molecular Weight) Market Share by Application in 2023 & 2030
    Figure 10. Treatment of Venous Thromboembolism
    Figure 11. Complications of Pregnancy
    Figure 12. Cardioversion of Atrial Fibrillation/Flutter
    Figure 13. Others
    Figure 14. Global Heparin (Low Molecular Weight) Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Heparin (Low Molecular Weight) Market Size (2019-2030) & (US$ Million)
    Figure 16. Global Heparin (Low Molecular Weight) Sales (2019-2030) & (Kiloton)
    Figure 17. Global Heparin (Low Molecular Weight) Average Price (US$/Ton) & (2019-2030)
    Figure 18. Heparin (Low Molecular Weight) Report Years Considered
    Figure 19. Heparin (Low Molecular Weight) Sales Share by Manufacturers in 2023
    Figure 20. Global Heparin (Low Molecular Weight) Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest Heparin (Low Molecular Weight) Players: Market Share by Revenue in 2023
    Figure 22. Heparin (Low Molecular Weight) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global Heparin (Low Molecular Weight) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America Heparin (Low Molecular Weight) Sales Market Share by Country (2019-2030)
    Figure 25. North America Heparin (Low Molecular Weight) Revenue Market Share by Country (2019-2030)
    Figure 26. U.S. Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe Heparin (Low Molecular Weight) Sales Market Share by Country (2019-2030)
    Figure 29. Europe Heparin (Low Molecular Weight) Revenue Market Share by Country (2019-2030)
    Figure 30. Germany Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Heparin (Low Molecular Weight) Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific Heparin (Low Molecular Weight) Revenue Market Share by Region (2019-2030)
    Figure 37. China Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Taiwan Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Indonesia Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Thailand Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Malaysia Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Philippines Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Latin America Heparin (Low Molecular Weight) Sales Market Share by Country (2019-2030)
    Figure 48. Latin America Heparin (Low Molecular Weight) Revenue Market Share by Country (2019-2030)
    Figure 49. Mexico Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Brazil Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Argentina Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Middle East & Africa Heparin (Low Molecular Weight) Sales Market Share by Country (2019-2030)
    Figure 53. Middle East & Africa Heparin (Low Molecular Weight) Revenue Market Share by Country (2019-2030)
    Figure 54. Turkey Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. UAE Heparin (Low Molecular Weight) Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. Global Sales Market Share of Heparin (Low Molecular Weight) by Type (2019-2030)
    Figure 58. Global Revenue Market Share of Heparin (Low Molecular Weight) by Type (2019-2030)
    Figure 59. Global Heparin (Low Molecular Weight) Price (US$/Ton) by Type (2019-2030)
    Figure 60. Global Sales Market Share of Heparin (Low Molecular Weight) by Application (2019-2030)
    Figure 61. Global Revenue Market Share of Heparin (Low Molecular Weight) by Application (2019-2030)
    Figure 62. Global Heparin (Low Molecular Weight) Price (US$/Ton) by Application (2019-2030)
    Figure 63. Heparin (Low Molecular Weight) Value Chain
    Figure 64. Heparin (Low Molecular Weight) Production Process
    Figure 65. Channels of Distribution (Direct Vs Distribution)
    Figure 66. Distributors Profiles
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions